Related Experiment Video
Updated: May 30, 2026
02:37
Robot-Assisted Transcanal Endoscopic Ear Surgery for Congenital Cholesteatoma
Published on: December 15, 2023
TNF-R2 expression in acquired middle ear cholesteatoma
Rodrigo Faller Vitale1, Celina Siqueira Barbosa Pereira2, Adriana Leal Alves3
1PhD, preceptor.
Brazilian Journal of Otorhinolaryngology
|August 24, 2011
Summary
Tumor necrosis factor alpha type 2 receptor (TNF-R2) is found in middle ear cholesteatoma. However, its presence does not correlate with the level of inflammation in patients with this bone-eroding disease.
Area of Science:
- Otolaryngology
- Immunology
- Pathology
Background:
- Acquired middle ear cholesteatoma is a destructive condition causing bone erosion and potential complications.
- Tumor necrosis factor alpha (TNF-α) is implicated in cholesteatoma-related bone erosion.
- Understanding cholesteatoma aggressiveness requires knowledge of receptor distribution and expression.
Purpose of the Study:
- To investigate the expression of type 2 TNF-α receptor (TNF-R2) in cholesteatoma tissue.
- To determine if TNF-R2 expression correlates with the degree of inflammation in cholesteatoma.
Main Methods:
- An observational, cross-sectional study analyzed 33 cholesteatoma fragments.
- Histological analysis and immunohistochemistry were employed to detect TNF-R2.
- Statistical analysis included Fisher exact test and Spearman's correlation coefficient.
Main Results:
- TNF-R2 expression was detected in all analyzed cholesteatoma fragments.
- No statistically significant correlation was found between TNF-R2 expression and the degree of inflammation.
Conclusions:
- Type 2 TNF-α receptor (TNF-R2) is consistently present in middle ear cholesteatoma.
- The expression level of TNF-R2 is not directly associated with the observed inflammation in cholesteatoma patients.
